Trial Profile
A pilot study to evaluate high doses of incobotulinumtoxinA in adult patients with severe spasticity after brain injury and cerebral palsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 20 Dec 2015 New trial record